🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Super important

Data for Victoria, Australia

Here are the costs in the US of the monoclonal antibody (Nirsevimab) to protect infants from RSV: 500 USD = 475 Euros Very nice article explaining the challenges of implementing this intervention when the issues of reimbursement are not clear cnn.com/2023/10/04/hea…

It is of note that Palivizumab costs roughly 1000 Euros in Europe #RSV

Very nice to have given this talk today at the University of Pisa Thank you Caterina Rizzo for the kind hospitality

Very happy to give this talk today at the University of Florence Università di Firenze It is going to be a very interesting session

Decreasing SARS-CoV-2 activity in Lyon, France ➡️ Peak week 39/2023 (decrease in number of cases and % positive) ➡️ Adults were mainily affected during this epidemic (those aged 18+ years) BEHcl

Important PROMISE Project publication on Rules of Collaboration to ensure the neutrality of public partners and their transparent engagement with industry imi-promise.eu/news/promise-c…

Interesting Scientific American report on life expectancy in the US (and other countries) after the COVID-19 pandemic Important: Some countries in Eastern Europe (e.g. Bulgaria) are seeing similar declines to the US scientificamerican.com/article/why-li…

Status of universal RSV immunisation in European Union countries Louis Bont Only two countries in the EU have started this winter: France and Spain thelancet.com/journals/lanep…

Publication of the September 2023 FluCov Bulletin ➡️ tinyurl.com/3mhts5br Globally, influenza activity is currently at an inter-seasonal level (see Figure) ➡️nivel.nl/en/project/flu…

A new world 63% of postdocs surveyed used ChatGPT to refine their texts nature.com/articles/d4158…

Another interesting one: 'I’ve always hated writing grants. Like most scientists, I love having scientific ideas, and I love drawing diagrams and writing up my ideas.' ChatGPT to the rescue! nature.com/articles/d4158…

Important: Publication of a new RSV surveillance bulletin PROMISE Project See: imi-promise.eu/surveillance/p… Many thanks to all participating national public health institutes, including RIVM and @Nivel_research In the future, we will add more countries, age and sequence data

Interesting #RSV paper  'The findings show the disrupted seasonality during the COVID-19 pandemic and a historically high surge of paediatric RSV cases [in the US] that required medical attention in 2022 fmch.bmj.com/content/11/4/e…

This is alo what I am hearing in France reuters.com/business/healt…

There's a new surveillance Bulletin in town! And its called the 'European Respiratory Virus Surveillance Summary (ERVISS)' The ERVISS Bulletin covers influenza, RSV and SARS-CoV-2 Congratulations to all involved ➡️ erviss.org

Trouble on the horizon

Publication of the 2nd PROMISE Project RSV Surveillance Bulletin ➡️RSV activity is now being reported in Denmark and the Netherlands ➡️In Austria, France, Portugal and Slovenia, RSV activity remained sporadic, with an increasing trend in France Congratulations to all involved 🙌

Interesting to see that France has moved to an acute respiratory infection (ARI) surveillance system to monitor all respiratory infections ➡️Since week 39/2023, one is mainly seeing SARS-CoV-2 and rhinovirus circulation, but also RSV since week 42/2023 ➡️sentiweb.fr/france/fr/?pag…